Amersham to Distribute Gene Logic s Products in Japan | GenomeWeb

NEW YORK, Sept 26 – Gene Logic (Nasdaq: GLGC) said Tuesday it had reached a deal that would give Amersham Pharmacia Biotech K.K. the exclusive rights to market sell Gene Logic’s products in Japan.

Under the terms of the deal, Amersham Pharmacia Biotech K.K, the Japanese subsidiary of Amersham Pharmacia Biotech, will market and sell Gene Logic’s range of databases and software tools to Japanese pharmaceutical and biotech companies.

Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."